Arix Bioscience plc Issue of Ordinary Shares and Total Voting Rights

 
TIDMARIX 
 
Arix Bioscience plc 
 
Issue of Ordinary Shares and Total Voting Rights 
 
Arix Bioscience plc (the "Company") announces that it has allotted 530,000 new 
Ordinary Shares to the Arix Bioscience plc Employee Benefit Trust in order to 
satisfy awards made under the Arix Bioscience plc Executive Incentive Plan. 
 
Application has been made for 530,000 new Ordinary Shares to be admitted to the 
standard segment of the Official List and to trading on the Main Market of the 
London Stock Exchange. The new Ordinary Shares will rank pari passu with the 
existing ordinary shares and it is expected that admission of these new 
Ordinary Shares will take place at 8.00 a.m. on 2 May 2019. 
 
Following the issue of 530,000 shares the Company will have a total of 
135,467,601 ordinary shares of GBP0.00001 each in issue and a total number of 
voting rights in the Company of 135,467,601. The above figure of 135,467,601 
may be used by shareholders as the denominator for the calculation by which 
they may determine if they are required to notify their interest in, or change 
to their interest in, the Company under the FCA's Disclosure Guidance and 
Transparency Rules. 
 
For further information: 
 
Robert Lyne                        Company Secretary 
[phone] 
 
 - Ends - 
 
 
 
END 
 

(END) Dow Jones Newswires

May 03, 2019 08:28 ET (12:28 GMT)